glp-1 이란 제제에 비만 적응증을 허하다 < 내분비/신장 < 내분비/신장 < 학술 < 기사본문 꿈의 비만 치료제 위고비 A
Description
This partial reversal may be driven by factors such as compliance challenges, waning drug efficacy, or measurement limitations
[PubMed] [Google Scholar] 73.Campbell JE

Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as they prepare for the next sea change in how patients receive their drugs
If more than 5 days have passed, skip the missed dose and take your next dose on the scheduled day
PMID: 40471562
